Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.11.21
Z6尊龙:关于修订公司治理相关制度的通告
2023.11.21
Z6尊龙:关于召开2023年第一次暂时股东大会、2023年第一次A股种别股东聚会及第一次H股类...
2023.08.30
Z6尊龙:2023年半年度报告摘要
2023.08.30
Z6尊龙:自力董事关于控股股东及其他关联方占用公司资金、公司对外担保情形的专项说明和...
2023.08.30
Z6尊龙:关于控股股东允许不减持公司股份的通告
2023.08.21
Z6尊龙:自力董事关于第六届董事会第二次聚会相关事项的自力意见
2023.08.21
Z6尊龙:关于变换财务总监的通告
2023.08.21
Z6尊龙:第六届董事会第二次聚会决议通告
2023.07.15
Z6尊龙:2023年半年度业绩预告
2023.07.11
Z6尊龙:2022年年度权益分派实验通告
第一页
上一页
3
4
5
6
7
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】